These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19304556)

  • 1. Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.
    Dessalew N
    Acta Pharm; 2009 Mar; 59(1):31-43. PubMed ID: 19304556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR study on dual 5-HT1A and 5-HT1B antagonists: an insight into the structural requirement for antidepressant activity.
    Dessalew N
    Arch Pharm (Weinheim); 2008 May; 341(5):314-22. PubMed ID: 18389517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
    Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
    J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study of substituted 1,3,4-oxadiazole naphthyridines as HIV-1 integrase inhibitors.
    Ravichandran V; Shalini S; Sundram K; Sokkalingam AD
    Eur J Med Chem; 2010 Jul; 45(7):2791-7. PubMed ID: 20347187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors.
    Gupta P; Roy N; Garg P
    Eur J Med Chem; 2009 Nov; 44(11):4276-87. PubMed ID: 19647906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
    Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Neamati N
    ChemMedChem; 2006 Feb; 1(2):238-44. PubMed ID: 16892356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR study of carboxylic acid derivatives as HIV-1 Integrase inhibitors.
    Cheng Z; Zhang Y; Fu W
    Eur J Med Chem; 2010 Sep; 45(9):3970-80. PubMed ID: 20561721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemistry and structure-activity relationship of HIV-1 integrase inhibitor integracide B and related natural products.
    Singh SB; Ondeyka JG; Schleif WA; Felock P; Hazuda DJ
    J Nat Prod; 2003 Oct; 66(10):1338-44. PubMed ID: 14575434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; QuiƱones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
    Pace P; Spieser SA; Summa V
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster analysis and three-dimensional QSAR studies of HIV-1 integrase inhibitors.
    Yuan H; Parrill A
    J Mol Graph Model; 2005 Jan; 23(4):317-28. PubMed ID: 15670952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.
    de Melo EB; Ferreira MM
    Eur J Med Chem; 2009 Sep; 44(9):3577-83. PubMed ID: 19327872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. QSAR study of curcumine derivatives as HIV-1 integrase inhibitors.
    Gupta P; Sharma A; Garg P; Roy N
    Curr Comput Aided Drug Des; 2013 Mar; 9(1):141-50. PubMed ID: 23286784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.